Introduction:In emergence a COVID patient with multisystem inflammatory syndrome in
children (MIS-C), associated with SARS-CoV-2, has shown increasing number among
pediatric. Even the same presentation of Kawasaki disease we have to keep in
mind MIS-C, in order to reach a consensus on this new disease in the future.
Three variations of the disease patterns were reported: a group of children
with increase in inflammatory activity and persistent fever, without criteria
for Kawasaki disease, a second group with Kawasaki disease criteria, and a
third group with shock, coronary aneurysms, severe cardiac dysfunction, and
gastrointestinal symptoms. Classic Kawasaki disease is self-limited vasculitis
which affects medium-sized vessels, almost occurred in children under five
years old. Here, we bring a Saudi case, present to emergency department in
Prince Sultan Military Medical City. Case report: 10 years old female,
medically free, presented with abdominal pain, fever and skin rashes. Patient
had history of COVID-19 infection 1 month before presentation.Initial investigations
showed acute kidney injury with elevated inflammatory markers. Conclusion: Further
evidence of the increase in the incidence of
pediatric MIS-C, temporarily is associated with SARS-CoV-2. Physician should give more attentions to this new diagnosis
with more fatal outcomes than Kawasaki cases.
References
[1]
ACC Clinical Bulletin COVID-19 Clinical Guidance for the Cardiovascular Care Team.
https://www.acc.org/membership/sections-and-councils/international-center/latest-news/2020/02/14/13/58/acc-clinical-bulletin-focuses-on-cardiac-implications-of-coronavirus-covid-19
[2]
Zhu, N., Zhang, D., Wang, W., et al. (2020) A Novel Coronavirus from Patients with Pneumonia in China, 2019. The New England Journal of Medicine, 382, 727-733.
https://doi.org/10.1056/NEJMoa2001017
[3]
Huang, C., Wang, Y., Li, X., et al. (2020) Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan, China. The Lancet, 395, 497-506.
https://doi.org/10.1016/S0140-6736(20)30183-5
[4]
Yonker, L.M., Shen, K. and Kinane, T.B. (2020) Lessons Unfolding from Pediatric Cases of COVID-19 Disease Caused by SARS-CoV-2 Infection. Pediatric Pulmonology, 55, 1085-1086. https://doi.org/10.1002/ppul.24748
[5]
Dong, Y., Mo, X., Hu, Y., et al. (2020) Epidemiology of COVID-19 among Children in China. Pediatrics, 145, e20200702. https://doi.org/10.1542/peds.2020-0702
[6]
Xiao, F., Tang, M., Zheng, X., et al. (2020) Evidence for Gastrointestinal Infection of SARS-CoV-2. Gastroenterology, 158, 1831-1833.E3.
https://doi.org/10.1053/j.gastro.2020.02.055
[7]
Panupattanapong, S. and Brooks, E.B. (2020) New Spectrum of COVID-19 Manifestations in Children: Kawasaki-Like Syndrome and Hyperinflammatory Response. Cleveland Clinic Journal of Medicine, 2, 7 p.
https://doi.org/10.3949/ccjm.87a.ccc039
[8]
Verdoni, L., Mazza, A., Gervasoni, A., et al. (2020) An Outbreak of Severe Kawasaki-Like Disease at the Italian Epicentre of the SARS-CoV-2 Epidemic: An Observational Cohort Study. The Lancet, 395, 1771-1778.
https://doi.org/10.1016/S0140-6736(20)31103-X
[9]
Riphagen, S., Gomez, X., Gonzalez-Martinez, C., et al. (2020) Hyperinflammatory Shock in Children during COVID-19 Pandemic. The Lancet, 395, 1607-1608.
https://doi.org/10.1016/S0140-6736(20)31094-1
[10]
Mahase, E. (2020) Covid-19: Concerns Grow over Inflammatory Syndrome Emerging in Children. British Medical Journal, 369, m1710.
https://doi.org/10.1136/bmj.m1710
[11]
Toubiana, J., Poirault, C., Corsia, A., et al. (2020) Kawasaki-Like Multisystem Inflammatory Syndrome in Children during the Covid-19 Pandemic in Paris, France: Prospective Observational Study. British Medical Journal, 369, m2094.
https://doi.org/10.1136/bmj.m2094
[12]
Whittaker, E., Bamford, A., Kenny, J., et al. (2020) Clinical Characteristics of 58 Children with a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2. JAMA, 324, 259-269.
[13]
Kawasaki, T., Kosaki, F., Okawa, S., Shigematsu, I. and Yanagawa, H. (1974) A New Infantile Acute Febrile Mucocutaneous Lymph Node Syndrome (MLNS) Prevailing in Japan. Pediatrics, 54, 271-276. https://doi.org/10.1542/peds.54.3.271
[14]
Kato, H., Sugimura, T., Akagi, T., et al. (1996) Long-Term Consequences of Kawasaki Disease: A 10-to 21-Year Follow-Up Study of 594 Patients. Circulation, 94, 1379-1385. https://doi.org/10.1161/01.CIR.94.6.1379
[15]
American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, Council on Cardiovascular and Stroke Nursing, Council on Cardiovascular Surgery and Anesthesia, Council on Epidemiology and Prevention, McCrindle, B.W., Rowley, A.H., Newburger, J.W., et al. (2017) Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals from the American Heart Association. Circulation, 135, e927-e999.
https://doi.org/10.1161/CIR.0000000000000484
[16]
Rowley, A.H. (2018) Is Kawasaki Disease an Infectious Disorder? International Journal of Rheumatic Diseases, 21, 20-25. https://doi.org/10.1111/1756-185X.13213
[17]
Kobayashi, T., Saji, T., Otani, T., et al. (2012) Efficacy of Immunoglobulin Plus Prednisolone for Prevention of Coronary Artery Abnormalities in Severe Kawasaki Disease (RAISE Study): A Randomised, Open-Label, Blinded-Endpoints Trial. The Lancet, 379, 1613-1620. https://doi.org/10.1016/S0140-6736(11)61930-2
[18]
Ramcharan, T., Nolan, O., Lai, C.Y., et al. (2020) Paediatric Inflammatory Multisystem Syndrome: Temporally Associated with SARS-CoV-2 (PIMS-TS): Cardiac Features, Management and Short-Term Outcomes at a UK Tertiary Paediatric Hospital. Pediatric Cardiology, 41, 1391-1401.
https://doi.org/10.1007/s00246-020-02391-2
[19]
Zhang, J., Sun, Y., Zhu, Z. and Zheng, J. (2021) Research Progress on a SARS-CoV-2 Vaccine in China. Journal of Biosciences and Medicines, 9, 76-88.
https://doi.org/10.4236/jbm.2021.911008
